To celebrate the new StarDrop and Manifold integration, Matt Segall (Optibrium, CEO), Aaron Morris (PostEra, CEO), and Emily Ripka (PostEra, Head of Product) unite to discuss synthesis prediction in drug discovery workflows. Learn more about how AI, machine learning and other computational tools can support the discovery process, bringing you feasible synthetic routes to your target compounds.
In this webinar:
- Watch live demonstrations of the Manifold synthesis prediction tool, Optibrium’s StarDrop drug discovery software, and their combined applications.
- Discover more about synthesis prediction and synthesis-aware design for small molecule drug discovery.
- Learn how AI tools can help identify effective synthetic routes as part of a seamlessly integrated data workflow
Other webinars you may be interested in
Finding balance in drug discovery through multi-parameter optimisation
Successful drugs require a delicate balance of many properties, such as potency, ADME and toxicity, to meet a project’s therapeutic objective. To make decisions about compound progression and assay selection, the available data must be assessed against project-specific criteria. However, the data on which we base our decisions often come from different sources and can vary in quality, so how can we use this information to make confident decisions? In addition, how can we be sure that the criteria we’re using are the most appropriate?
